Tap here to turn on desktop notifications to get the news sent straight to you.
Join HuffPost Plus
Helping The Neediest Patients: Stopping Insurers' Rejection Of Prescription Medications
Michael D. Shaw
Business owner, commentator, righter
We can ill afford more of the same from these institutions. The stakes are too high, and the fallout is too great, for the status quo to endure. We deserve justice, not more excuses and more attempts to deprive us of the medicines we have a right to receive.
Why Are The Costs Of Cancer Drugs So High?
Award winning blogger, two time Breast Cancer Survivor, Patien...
Personally, I have always found it difficult to believe that pharmaceutical companies were in the business of cancer research
Brendan McDermid / Reuters
Big Pharma Just Bet $10 Billion On A Cancer Drug Startup. Here's Why.
"This deal is going to end up looking either very smart or very stupid."
Photography by ZhangXun via Getty Images
The U.S. Throws Out $3 Billion In Cancer Drugs Every Year
By Lisa Rapaport, Reuters
This little-known practice is driving up healthcare costs.
The Problem With Most Cancer Drugs Recently Approved By The FDA
Founder and CEO, JustCareUSA.org, a digital platform for boome...
According to a new study in JAMA, there is no evidence that the majority of the U.S. Food and Drug Administration-approved cancer drugs over the last five years work.
BSIP/UIG via Getty Images
American Cancer Patients Pay Twice As Much For Drugs As Europeans
By Ben Hirschler, Reuters
The fight over prescription drug prices is only just beginning.
Refocusing Cancer Drug Approval on Patients
Mikkael A. Sekeres, MD, MS
What the 21st Century Cures Act ignores is the prevailing, patient agnostic approach to drug development. We need to move toward a patient-centric approach to drug development and approval, and we should start with cancer treatments.
High Costs of Cancer Drugs
Advocate, Activist, Author
We are in a different time period thanks to scientific discovery. Our health care system and our views of what cancer looks like need to expand to match up with where we are.
Pfizer Chases AstraZeneca In Effort To Launch Biggest Ever Foreign Takeover Of British Company
By Reuters, Reuters
LONDON/NEW YORK, April 28 (Reuters) - U.S. drugmaker Pfizer Inc approached Britain's AstraZeneca Plc two days ago to reignite
Andrea Sloan Faces Pharma Firm With History Of Indifference
"You feel helpless, almost like the world's gone mad," she recalled. "This isn't happening. Surely, in the U.S. and the U.K
Do you have info to share with HuffPost reporters?
The Cancer Drug That Could Save My Life
Teacher, British Council Bangladesh
I'm from Bangladesh and 27 years old. I was born in a society where anyone hardly heard the word C-A-N-C-E-R. So in face of impossible odds my physician suggested chemotherapy accompanied by Rituxan (a biologic drug), but I was unable to afford it because the drug costs a fortune.
The Cost of Cancer Drugs and Research
Advocate, Activist, Author
In their Intellectual property case, the pharmaceutical company Novartis was asking to block a generic form of their cancer drug Gleevec from being created and sold by India. As a writer and also a person living with chronic myelogenous leukemia, I understand both sides of the battle.
The Economics of Cancer: Learning From India About Innovation
researcher and activist on global health, policy, human rights
But what if you want to incentivize investment in bold new drugs instead of me-too drugs? What if you want to encourage research into new areas that tangibly improve people's health? Then maybe, like India, you would only grant patents when that higher standard is met.
New Treatments, Your Health and Statistics
President, American Statistical Association; Professor, NC State
Statisticians and statistics are even more fundamental in this era of personalized medicine, as sponsors seek to target treatment to patients most likely to benefit and develop "adaptive" study designs to identify these patients sooner.
We Can Prevent Cancer Before Curing It
Founder of the Blue Cure prostate cancer nonprofit. Cancer pre...
Don't get me wrong. We must continue to support the goal of conquering cancer. But we must ask the National Cancer Institute to allocate more funding for prevention, and we must research better, more accurate diagnostics.
Fighting Cancer: Better Models Make Better Drugs
Corporate Vice President, Charles River Laboratories, Discover...
The realities of pharmaceutical research are brutal, consisting of decade-and-a-half long timescales, mind-numbing costs and exceedingly long, soul-crushing odds of success. In the fight against cancer, this rings especially true.
University of Miami Employee, Manuel Pacheco, Allegedly Looted Pharmacy For Over $14 Million In Cancer Drugs
Watch the video footage below He's pleaded not guilty to charges of four counts of grand theft, two counts of trafficking
Drug Costs Becoming Bigger Issue In Cancer Care
By Reuters, Reuters
Research led by Dr. Thomas Smith of Johns Hopkins Medicine, concluded that practice patterns need to be changed, in part
Doctors Warn Of U.S. Cancer Drug Shortage
Dr. Richard Schilsky, cancer specialist at the University of Chicago and a past ASCO president, said the shortages have been
Chase Chesbro, Kid With Leukemia, Has Life-Saving Medication Stolen In Parking Lot (VIDEO)
A Colorado purse thief may be feeling guiltier this month than he normally does after a heist. That's because the purse he
Genentech, Innovative Cancer Drug Maker, Receives $43.7B Offer From Roche Holding
PARIS -- The Swiss drug maker Roche Holding said Monday that it was offering about $43.7 billion to acquire the 44 percent
Medicare To Stop Paying For Two Cancer Drugs
New Medicare rules for a small but promising class of cancer drugs may cause thousands of lymphoma patients to lose access
Switzerland to Thailand: Drop Dead
Director, Knowledge Ecology International
Recently, the Swiss government wrote a letter to the Thai government, objecting to the use of compulsory licenses to obtain affordable cancer drugs in Thailand.
Real Life. Real News. Real Voices.
Help us tell more of the stories that matter from voices that too often remain unheard.
Join HuffPost Plus
Culture & Arts
TV & Film
Style & Beauty
Food & Drink
Home & Living
Impact: Project Zero
Impact: This New World
Listen to America
From Our Partners
What's Working: Purpose + Profit